News

April 17, 2023

MatTek and NEXT Oncology Announce Licensing Agreement

The Boston-based biotech company will use an inventory of patient-derived cancer cells to develop new lab-grown tumor models to accelerate and refine oncology research, and provide more targeted treatments for cancer patients. [For immediate release: Ashland, MA and San Antonio,... Read More

April 12, 2023

Register Now for Our Medical Devices Webinar

Register now for a webinar on medical devices with expert panelists discussing current accepted methods and future outlooks.

March 30, 2023

MatTek and Visikol Announce Commercial Integration

MatTek CEO Alex Armento and Visikol CEO Dr. Michael Johnson, announced a commercial integration under the MatTek name.

February 22, 2023

MatTek Launches New Lab Grown Human Nasal Tissue

MatTek Life Sciences announced the launch of their newest lab-grown, three-dimensional human tissue, EpiNasal.

January 18, 2023

MatTek Delivers First Annual University Course

MatTek has taken the next step in its education program by delivering a curriculum in the Master of Biotechnology at the prestigious Sorbonne University in Paris, France. The world’s leading producer of 3D human reconstructed tissues as an alternative to animal testing, MatTek has a long commitment to share its expertise and to educate the next generation of scientists about this technology.